Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. Jul 15, 2024; 16(7): 3082-3096
Published online Jul 15, 2024. doi: 10.4251/wjgo.v16.i7.3082
Published online Jul 15, 2024. doi: 10.4251/wjgo.v16.i7.3082
Figure 9 Correlation, difference, and survival curve analyses between miR-19b-3p- BCAR3-related long-stranded non-coding RNA and miRNA in hepatocellular carcinoma, respectively.
A: Negative regulatory relationship between MIR34AHG long-stranded non-coding RNA (lncRNA) and miR-19b-3p, analyzed by Spearman correlate analysis; B: Differential expression of MIR34AHG lncRNA in hepatocellular carcinoma (HCC) tissue; C: Positive regulatory relationship between RAB30-DT lncRNA and miR-19b-3p, analyzed by Spearman correlate analysis; D: Differential expression of RAB30-DT in HCC tissue; E: Kaplan-Meier survival analysis of MIR34AHG lncRNA expression in HCC patients; F: Kaplan-Meier survival analysis of RAB30-DT lncRNA expression in HCC patients. aP value < 0.05.
- Citation: Shi HQ, Huang S, Ma XY, Tan ZJ, Luo R, Luo B, Zhang W, Shi L, Zhong XL, Lü MH, Chen X, Tang XW. BCAR3 and BCAR3-related competing endogenous RNA expression in hepatocellular carcinoma and their prognostic value. World J Gastrointest Oncol 2024; 16(7): 3082-3096
- URL: https://www.wjgnet.com/1948-5204/full/v16/i7/3082.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i7.3082